30 May 2025

---

Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement

---

This clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height.

All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success.

Read the full article here.

Authors: Ueda, Minoru; Yamada, Yoichi; Ozawa, Ryotaro; Okazaki, Yasuhiro

Source: https://openurl.ebsco.com/